findmyKOL
Clinical trialNCT01858259UnknownObservational

Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic Sclerosis

SponsorGabriela RiemekastenEnrollment1,372Interstitial Lung DiseasesSystemic Sclerosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Christopher Denton, Prof.

    Royal Free Hospital, University College London London

    Principal Investigator
  • Gabriela Riemekasten, Prof.

    Charité Universitätsmedizin Berlin, Charité Centrum 12 für Innere Medizin und Dermatologie, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie

    Principal Investigator
  • Ulf Müller-Ladner, Prof.

    Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology

    Study Chair

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Université Paris Descartes, Hôpital Cochin, Service de Rhumatologie A & Inserm 1016

    Paris, France

    Yannick Allanore, Prof.
    Recruiting
Germany
  • Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology

    Bad Nauheim, Germany

    Ingo H. Tarner, Dr.Marc Frerix, Dr.Ulf Müller-Ladner, Prof.
    Recruiting
  • Charité Universitätsmedizin Berlin, Charité Centrum 12 Für Innere Medizin Und Dermatologie, Medizinische Klinik Mit Schwerpunkt Rheumatologie Und Klinische Immunologie

    Berlin, Germany

    Gabriela Riemekasten, Prof.
    Recruiting
  • Centre for Pediatric Rheumatology, Klinikum Eilbek

    Hamburg, Germany

    Ivan Foeldvari, Dr.
    Recruiting
Hungary
  • Pecsi Tudomanyegyetem - University of Pecs

    Pécs, Hungary

    Laszlo Czirjak, Prof.
    Recruiting
Italy
  • University of Florence, Denothe Centre, Division of Rheumatology Aouc, Department of Biomedicine

    Florence, Italy

    Marco Matucci-Cerinic, Prof.
    Recruiting
  • Policlinico, Via Pansini

    Napoli-Italia, Italy

    Gabriele Valentini, Prof
    Recruiting
Switzerland
  • Felix-Platter Spital, University of Basel

    Basel, Switzerland

    Ulrich Walker, Prof.
    Recruiting
  • University of Zurich, Department of Rheumatology

    Zurich, Switzerland

    Oliver Distler, Prof.
    Recruiting
United Kingdom
  • the Universitiy of Leeds, Division of Rheumatic and Musculoskeletal Disease, St James'S University Hospital

    Leeds, United Kingdom

    Francesco Del Galdo, Dr.
    Recruiting
  • Royal Free Hospital, University College London

    London, United Kingdom

    Christopher Denton, Prof.
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2013
Primary completion
30 Jun 2016
Completion
30 Jun 2016
Last update posted
13 Aug 2014
Registered enrollment
1,372
Registry id
NCT01858259

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.